Bladder Cancer (NMIBC) in a population-based cohort from Stockholm County with long-term follow-up; A comparative analysis of prediction models for recurrence and progression, including external validation of the updated 2021 E.A.U. model
Zachary Dovey(Icahn School of Medicine at Mount Sinai), Peter Wiklund(Unknown), John P. Sfakianos(Mount Sinai Medical Center), Gunnar Steineck(University of Gothenburg), Alberto Martini(The University of Texas MD Anderson Cancer Center), Lotta Renström Koskela(Karolinska University Hospital), John Pfail(Icahn School of Medicine at Mount Sinai), Abolfazl Hosseini(Karolinska University Hospital), Linda Dey(Karolinska University Hospital)
Urologic Oncology Seminars and Original Investigations
November 25, 2021
Cited by 13
Related Papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|656
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
|Annals of the Rheumatic Diseases|2001|287
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
|European Urology|2025|190